![D. Kirkpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Kirkpatrick
Algemeen Directeur bij
ENSYSCE BIOSCIENCES, INC.
Vermogen: 30 $ op 31-05-2026
Profiel
D.
Lynn Kirkpatrick was the founder of ProlX Pharmaceuticals Corp., founded in 1999, serving as President & Chief Executive Officer from 1999 to 2006.
Dr. Kirkpatrick is the founder of Phusis Therapeutics, Inc., founded in 2009.
Dr. Kirkpatrick currently holds the position of President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., starting in 2009.
Former positions include President, Chief Executive Officer & Director at Ensysce Biosciences, Inc., Director at BiologicsMD, Inc., Chief Scientific Officer at Biomira, Inc., Professor at the University of Regina from 1983 to 2001, and Chief Scientific Officer at Cascadian Therapeutics LLC from 2006 to 2008.
Education includes undergraduate and doctorate degrees from the University of Saskatchewan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-11-2025 | 107 ( 0% ) | 30 $ | 31-05-2026 |
Actieve functies van D. Kirkpatrick
| Bedrijven | Functie | Begin |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Algemeen Directeur | 01-01-2009 |
Eerdere bekende functies van D. Kirkpatrick
| Bedrijven | Functie | Einde |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Hoofd Techniek/Wetenschap/O&O | 31-12-2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Hoofd Techniek/Wetenschap/O&O | 11-12-2007 |
ProlX Pharmaceuticals Corp.
 ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Algemeen Directeur | 01-01-2006 |
University of Regina
 University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2001 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Oprichter | - |
Opleiding van D. Kirkpatrick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
University of Regina
University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
BiologicsMD, Inc.
 BiologicsMD, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical therapeutic development company which focuses on smart therapies for hair loss and bone disorders | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProlX Pharmaceuticals Corp.
ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Health Technology |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
Ensysce Biosciences, Inc.
 Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
